Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Muller

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Neuroendocrinology|January 1, 1987
Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of actionP Schoenenberg, P Kehrer, A F Muller, et al.
Endocrinology|July 1, 1990
Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factorsR C Gaillard, D Turnill, P Sappino, et al.
Helvetica Medica Acta|April 1, 1970
3. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in patients with Addison's diseaseA Grandchamp, R Veyrat, R S Mach, et al.
Acta Endocrinologica|January 1, 1987
cAMP-dependent ACTH secretagogues facilitate corticotropin releasing activity of angiotensin II on rat anterior pituitary cells in vitroP Schoenenberg, R C Gaillard, P Kehrer, et al.
Fertility and Sterility|February 6, 1999
Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilizationA F Muller, A Verhoeff, M J Mantel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1989
Specific effect of CV 205-502, a potent nonergot dopamine agonist, during a combined anterior pituitary function testR C Gaillard, K Abeywickrama, J Brownell, et al.
Digestion|January 1, 1992
The integrated response of the cardiovascular system to foodA F Muller, L Fullwood, M Hawkins, et al.
Life Sciences|January 1, 1988
Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressinR C Gaillard, A M Riondel, N Ling, et al.
Schweizerische Medizinische Wochenschrift|March 24, 1979
[Cholestyramine and digoxin intoxication: therapeutic efficacy?]F Frésard, L Balant, J Noble, et al.
Clinical Science (London, England : 1979)|October 1, 1990
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro ratsA F Muller, S M Gardiner, A M Compton, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Neuroendocrinology|January 1, 1987
Angiotensin II potentiates corticotropin-releasing activity of CRF41 in rat anterior pituitary cells: mechanism of actionP Schoenenberg, P Kehrer, A F Muller, et al.
Endocrinology|July 1, 1990
Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factorsR C Gaillard, D Turnill, P Sappino, et al.
Helvetica Medica Acta|April 1, 1970
3. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in patients with Addison's diseaseA Grandchamp, R Veyrat, R S Mach, et al.
Acta Endocrinologica|January 1, 1987
cAMP-dependent ACTH secretagogues facilitate corticotropin releasing activity of angiotensin II on rat anterior pituitary cells in vitroP Schoenenberg, R C Gaillard, P Kehrer, et al.
Fertility and Sterility|February 6, 1999
Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilizationA F Muller, A Verhoeff, M J Mantel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1989
Specific effect of CV 205-502, a potent nonergot dopamine agonist, during a combined anterior pituitary function testR C Gaillard, K Abeywickrama, J Brownell, et al.
Digestion|January 1, 1992
The integrated response of the cardiovascular system to foodA F Muller, L Fullwood, M Hawkins, et al.
Life Sciences|January 1, 1988
Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressinR C Gaillard, A M Riondel, N Ling, et al.
Schweizerische Medizinische Wochenschrift|March 24, 1979
[Cholestyramine and digoxin intoxication: therapeutic efficacy?]F Frésard, L Balant, J Noble, et al.
Clinical Science (London, England : 1979)|October 1, 1990
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro ratsA F Muller, S M Gardiner, A M Compton, et al.
Pageof 11